-
Something wrong with this record ?
Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative
DA. Sarigiannis, S. Karakitsios, E. Dominguez-Romero, K. Papadaki, C. Brochot, V. Kumar, M. Schuhmacher, M. Sy, H. Mielke, M. Greiner, M. Mengelers, M. Scheringer,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Models, Biological * MeSH
- Biological Monitoring * MeSH
- Quantitative Structure-Activity Relationship MeSH
- Humans MeSH
- Toxicokinetics * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Given the opportunities provided by internal dosimetry modelling in the interpretation of human biomonitoring (HBM) data, the assessment of the links between exposure to chemicals and observed HBM data can be effectively supported by PBTK modelling. This paper gives a comprehensive review of available human PBTK models for compounds selected as a priority by the European Human Biomonitoring Initiative (HBM4EU). We highlight their advantages and deficiencies and suggest steps for advanced internal dose modelling. The review of the available PBTK models highlighted the conceptual differences between older models compared to the ones developed recently, reflecting commensurate differences in research questions. Due to the lack of coordinated strategies for deriving useful biomonitoring data for toxicokinetic properties, significant problems in model parameterisation still remain; these are further increased by the lack of human toxicokinetic data due to ethics issues. Finally, questions arise as well as to the extent they are really representative of interindividual variability. QSARs for toxicokinetic properties is a complementary approach for PBTK model parameterisation, especially for data poor chemicals. This approach could be expanded to model chemico-biological interactions such as intestinal absorption and renal clearance; this could serve the development of more complex generic PBTK models that could be applied to newly derived chemicals. Another gap identified is the framework for mixture interaction terms among compounds that could eventually interact in metabolism. From the review it was concluded that efforts should be shifted toward the development of generic multi-compartmental and multi-route models, supported by targeted biomonitoring coupled with parameterisation by both QSAR approach and experimental (in-vivo and in-vitro) data for newly developed and data poor compounds.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006559
- 003
- CZ-PrNML
- 005
- 20200520155013.0
- 007
- ta
- 008
- 200511s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.envres.2019.01.045 $2 doi
- 035 __
- $a (PubMed)30818231
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Sarigiannis, Dimosthenis A $u Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki 54124, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece. Electronic address: denis@eng.auth.gr.
- 245 10
- $a Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative / $c DA. Sarigiannis, S. Karakitsios, E. Dominguez-Romero, K. Papadaki, C. Brochot, V. Kumar, M. Schuhmacher, M. Sy, H. Mielke, M. Greiner, M. Mengelers, M. Scheringer,
- 520 9_
- $a Given the opportunities provided by internal dosimetry modelling in the interpretation of human biomonitoring (HBM) data, the assessment of the links between exposure to chemicals and observed HBM data can be effectively supported by PBTK modelling. This paper gives a comprehensive review of available human PBTK models for compounds selected as a priority by the European Human Biomonitoring Initiative (HBM4EU). We highlight their advantages and deficiencies and suggest steps for advanced internal dose modelling. The review of the available PBTK models highlighted the conceptual differences between older models compared to the ones developed recently, reflecting commensurate differences in research questions. Due to the lack of coordinated strategies for deriving useful biomonitoring data for toxicokinetic properties, significant problems in model parameterisation still remain; these are further increased by the lack of human toxicokinetic data due to ethics issues. Finally, questions arise as well as to the extent they are really representative of interindividual variability. QSARs for toxicokinetic properties is a complementary approach for PBTK model parameterisation, especially for data poor chemicals. This approach could be expanded to model chemico-biological interactions such as intestinal absorption and renal clearance; this could serve the development of more complex generic PBTK models that could be applied to newly derived chemicals. Another gap identified is the framework for mixture interaction terms among compounds that could eventually interact in metabolism. From the review it was concluded that efforts should be shifted toward the development of generic multi-compartmental and multi-route models, supported by targeted biomonitoring coupled with parameterisation by both QSAR approach and experimental (in-vivo and in-vitro) data for newly developed and data poor compounds.
- 650 12
- $a biologický monitoring $7 D000079687
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a biologické modely $7 D008954
- 650 _2
- $a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
- 650 12
- $a toxikokinetika $7 D066007
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Karakitsios, Spyros $u Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki 54124, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece.
- 700 1_
- $a Dominguez-Romero, Elena $u RECETOX, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Papadaki, Krystalia $u Aristotle University of Thessaloniki, Department of Chemical Engineering, Environmental Engineering Laboratory, University Campus, Thessaloniki 54124, Greece.
- 700 1_
- $a Brochot, Celine $u INERIS, France.
- 700 1_
- $a Kumar, Vikas $u IISPV, Tarragona, Spain.
- 700 1_
- $a Schuhmacher, Marta $u IISPV, Tarragona, Spain.
- 700 1_
- $a Sy, Moustapha $u BfR, Berlin, Germany.
- 700 1_
- $a Mielke, Hans $u BfR, Berlin, Germany.
- 700 1_
- $a Greiner, Mathias $u BfR, Berlin, Germany.
- 700 1_
- $a Mengelers, Marcel $u RIVM, Utrecht, the Netherlands.
- 700 1_
- $a Scheringer, Martin $u RECETOX, Masaryk University, Brno, Czech Republic.
- 773 0_
- $w MED00001557 $t Environmental research $x 1096-0953 $g Roč. 172, č. - (2019), s. 216-230
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30818231 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200520155012 $b ABA008
- 999 __
- $a ok $b bmc $g 1525417 $s 1096615
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 172 $c - $d 216-230 $e 20190129 $i 1096-0953 $m Environmental research. Section A $n Environ Res $x MED00001557
- LZP __
- $a Pubmed-20200511